Sterna Biologicals GmbH & Co. KG   Report issue

For profit Phase 2
Founded: Marburg Germany (2006)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2011
NCT01470911
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (4)

hgd40 (1 trial)

sb010 (4 trials)

sb011 (1 trial)

sb012 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 4